The absence of angiopoietin-2 leads to abnormal vascular maturation and persistent proliferative retinopathy

Summary

Angiopoietin-2 (Ang-2) antagonises the maturing effect of angiopoietin-1 (Ang-1) on blood vessels, and cooperates with VEGF to induce neovascularisation. In knockout mice,Ang-2 displayed a specific role in postnatal angiogenic remodelling. Here, we demonstrate that mice deficient in Ang-2 fail to form a proper spatial retinal vascular network. The retinal vasculature was characterised by reduced large vessel numbers and defects forming the superficial periphery mostly on the arteriolar site, and the secondary and tertiary deep capillary network. Hypoxia in the retinal periphery induced a four-fold VEGF upregulation and active endothelial proliferation for up to 60 days. Concomitantly, retinal digest preparations showed increased arteriolar (+33%) and capillary diameters (+90%), and fluorescein angiograms revealed leakiness of neovascular front. At one year of age, persistent preretinal vessels were non-leaky in accordance with a relative increase in the ratio of Ang-1 to VEGF.Taken together, the data suggest that Ang-2 has an important function in the spatial configuration of the three-dimensional retinal vasculature. Secondarily, prolonged VEGF activity results in a model of persistent proliferative retinopathy.

Keywords

Angiogenesis - VEGF - angiopoietin - proliferative retinopathy

• References

• 1 Frank RN. Diabetic retinopathy. N Engl J Med 2004; 350: 48-58.
• 2 Ferrara N, Damico L, Shams N. et al. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina 2006; 26: 859-870.
• 3 Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005; 438: 932-936.
• 4 Hanahan D. Signaling vascular morphogenesis and maintenance. Science 1997; 277: 48-50.
• 5 Maisonpierre PC, Suri C, Jones PF. et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277: 55-60.
• 6 Aiello LP, Avery RL, Arrigg PG. et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331: 1480-1487.
• 7 Watanabe D, Suzuma K, Suzuma I. et al. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Am J Ophthalmol 2005; 139: 476-481.
• 8 Hammes HP, Lin J, Bretzel RG. et al. Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. Diabetes 1998; 47: 401-406.
• 9 Hammes HP, Lin J, Wagner P. et al. Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy. Diabetes 2004; 53: 1104-1110.
• 10 Kuroki M, Voest EE, Amano S. et al. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest 1996; 98: 1667-1675.
• 11 Lu M, Kuroki M, Amano S. et al. Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest 1998; 101: 1219-1224.
• 12 Yao D, Taguchi T, Matsumura T. et al. High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A. J Biol Chem 2007; 282: 31038-31045.
• 13 Feng Y, vom Hagen F, Pfister F. et al. Impaired pericyte recruitment and abnormal retinal angiogenesis as a result of angiopoietin-2 overexpression. Thromb Haemost 2007; 97: 99-108.
• 14 Takagi H, Koyama S, Seike H. et al. Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization. Invest Ophthalmol Vis Sci 2003; 44: 393-402.
• 15 Umeda N, Ozaki H, Hayashi H. et al. Colocalization of Tie2, angiopoietin 2 and vascular endothelial growth factor in fibrovascular membrane from patients with retinopathy of prematurity. Ophthalmic Res 2003; 35: 217-223.
• 16 Gale NW, Thurston G, Hackett SF. et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell 2002; 03: 411-423.
• 17 Hackett SF, Ozaki H, Strauss RW. et al. Angiopoietin 2 expression in the retina: upregulation during physiologic and pathologic neovascularization. J Cell Physiol 2000; 184: 275-284.
• 18 Hammes HP, Brownlee M, Jonczyk A. et al. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat Med 1996; 02: 529-533.
• 19 Seeliger MW, Beck SC, Pereyra-Munoz N. et al. In vivo confocal imaging of the retina in animal models using scanning laser ophthalmoscopy. Vision Res 2005; 45: 3512-3519.
• 20 Gardiner TA, Gibson DS, de Gooyer TE. et al. Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy. Am J Pathol 2005; 166: 637-644.
• 21 Hackett SF, Wiegand S, Yancopoulos G. et al. Angiopoietin-2 plays an important role in retinal angiogenesis. J Cell Physiol 2002; 192: 182-187.
• 22 Chan CK, Pham LN, Zhou J. et al. Differential expression of proand antiangiogenic factors in mouse strain-dependent hypoxia-induced retinal neovascularization. Lab Invest 2005; 85: 721-733.
• 23 Stalmans I, Ng YS, Rohan R. et al. Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J Clin Invest 2002; 109: 327-336.
• 24 Dixit M, Bess E, Fisslthaler B. et al. Shear stress-induced activation of the AMP-activated protein kinase regulates FoxO1a and angiopoietin-2 in endothelial cells. Cardiovasc Res 2008; 77: 160-168.
• 25 Pierce EA, Avery RL, Foley ED. et al. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 1995; 92: 905-909.
• 26 Luhmann UF, Lin J, Acar N. et al. Role of the Norrie disease pseudoglioma gene in sprouting angiogenesis during development of the retinal vasculature. Invest Ophthalmol Vis Sci 2005; 46: 3372-3382.
• 27 Gerhardt H, Golding M, Fruttiger M. et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 2003; 161: 1163-1177.
• 28 Nguyen QD, Tatlipinar S, Shah SM. et al. Vascular endothelial growth factor is a critical stimulus for diabetic macular edema. Am J Ophthalmol 2006; 142: 961-969.
• 29 Uemura A, Ogawa M, Hirashima M. et al. Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells. J Clin Invest 2002; 110: 1619-1628.
• 30 Thurston G, Rudge JS, Ioffe E. et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000; 06: 460-463.
• 31 Smith LE, Wesolowski E, McLellan A. et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1994; 35: 101-111.